Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma

Laryngoscope

Volumn 125, Issue S3, 2015, Pages S1-S11

  John, Maie A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

COX 2.; E cadherin; EMT; HNSCC; Metastasis

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; ERLOTINIB; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; PROSTAGLANDIN E2; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; AUTACOID; CADHERIN; PTGS2 PROTEIN, HUMAN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER RESISTANCE; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; E BOX ELEMENT; EPITHELIAL MESENCHYMAL TRANSITION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LONG TERM SURVIVAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGIONAL METASTASIS; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; CARCINOMA, SQUAMOUS CELL; DRUG RESISTANCE; HEAD AND NECK NEOPLASMS; IMMUNOLOGY; MOUSE; PHYSIOLOGY; SECONDARY; TUMOR CELL CULTURE;

ANIMALS; CADHERINS; CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; HEAD AND NECK NEOPLASMS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; MICE; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 84923426342     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24998     Document Type: Conference Paper

References (44)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: Cancer incidence, mortality and prevalence worldwide, version 1.0. IARC Cancer Base No 5.
2. Zender CA, Petruzzelli GJ. Why do patients with head and neck squamous cell carcinoma experience distant metastases: can they be prevented? Curr Opin Otolaryngol Head Neck Surg 2005;2:101-104.
3. Li Y, St.John MA, Zhou X, et al. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 2004;24:8442-8450.
4. Lin DT, Subbaramaiah K, Shah JP, Dannenberg AJ, Boyle JO. Cyclooxy-genase-2: a novel molecular target for the prevention and treatment of head and neck cancer. Head Neck 2002;8:792-799.
5. Bancroft CC, Chen Z, Yeh J, et al. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NFkappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. Int J Cancer 2002;99: 538-548.
6. Wolf JS, Chen Z, Dong G, et al. IL (interleukin)21alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. Clin Cancer Res 2001;7:1812-1820.
7. Chen Z, Colon I, Ortiz N, et al. Effects of interleukin-1alpha, interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines. Cancer Res 1998;58:3668-3676.
8. Mukhopadhyay P, Ali MA, Nandi A, Carreon P, Choy H, Saha D. The cyclin-dependent kinase 2 inhibitor down-regulates interleukin-1βetamediated induction of cyclooxygenase-2 expression in human lung carcinoma cells. Cancer Res 2006;66:1758-1766.
9. Teruel A, Romero M, Cacalano NA, Head C, Jewett A. Potential contribution of naïve immune effectors to oral tumor resistance: role in synergistic induction of VEGF, IL-6, and IL-8 secretion. Cancer Immunol Immunother 2008;57:359-366.
10. Endo T, Ogushi F, Sone S, et al. Induction of cyclooxygenase-2 is responsible for interleukin-1 beta-dependent prostaglandin E2 synthesis by human lung fibroblasts. Am J Resp Cell Mol Biol 1995;12:358-365.
11. Tsai CC, Chen CC, Lin CC, et al. Interleukin-1 beta in oral submucous fibrosis, verrucous hyperplasia and squamous cell carcinoma tissues Kaohsiung. J Med Sci 1999;9:513-519.
12. Dohadwala M, Yang SC, Luo J, et al. Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. Cancer Res 2006;66:5338-5345.
13. Dohadwala M, Luo J, Zhu L, et al. Non small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44. J Biol Chem 2001;276:20809-20812.
14. Dohadwala M, Batra RK, Luo J, et al. Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion. J Biol Chem 2002;277:50828-50833.
15. Chen Z, Zhang X, Li M, et al. Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck. Clinical Cancer Res 2004;10:5930-5939.
16. Kang, Y Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004;118:277-279.
17. Bremnes RM, Veve R, Hirsch FR, Franklin WA. The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis and prognosis. Lung Cancer 2002;36:115-124.
18. Conacci-Sorrell M, Zhurinskey J, Ben-Ze'ev A. The cadherin catenin adhesion system in signaling and cancer. J Clin Invest 2002;109:987-991.
19. Ginos MA, Page GP, Michalowicz BS, et al. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res 2004;64:55-63.
20. Lyons JG, Patel V, Roue NC, et al. Snail up-regulates proinflammatory mediators and inhibits differentiation in oral keratinocytes. Cancer Res 2008;68:4525-4530.
21. Zhang X, Chen ZG, Choe MS, Shin D. Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft model. Clin Cancer Res 2005;11:6261-6269.
22. Hoteiya T, Hayashi E, Satomura K, Kamata N, Nagayama M. Expression of E-cadherin in oral cancer cell lines and its relationship to invasiveness in SCID mice in vivo. J Oral Pathol Med 1999;28:107-111.
23. Lee GY, Kenny PA, Lee EH, Bissell MJ. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods 2007;4: 359-365.
24. Yokoyama K, Kamata N, Fujimoto R, et al. Increased invasion and matrix metalloproteinase-2 expression by Snail-induced mesenchymal transition in squamous cell carcinomas. Int J Oncol 2003;22:891-898.
25. Sarantopoulos GP, Gui D, Shintaku P, et al. Immunohistochemical analysis of lung carcinomas with pure or partial bronchioloalveolar differentiation. Arch Pathol Lab Med 2004;128:406-414.
26. Krysan K, Merchant FH, Zhu L, et al. COX-2 dependent stabilization of surviving in non-small cell lung cancer. Faseb J 2004;18:206-208.
27. Moody SE, Perez D, Pan TC, et al. The transcriptional repressor snail promotes mammary tumor recurrence. Cancer Cell 2005;8:197-209.
28. Brabant G, Hoang-Vu C, Cetin Y, et al. E-cadherin: a differentiation marker in thyroid malignancies. Cancer Res 1993;53:4987-4993.
29. Naito A, Iwase H, Kuzushima T, Nakamura T, Kobayashi S. Clinical significance of E-cadherin expression in thyroid neoplasms. J Surg Oncol 2001;76:176-180.
30. Rocha AS, Soares P, Fonseca E, Cameselle-Teijeiro J, Oliveira MC, Sobrinho-Simoes M. E-cadherin loss rather than beta-catenin alterations is a common feature of poorly differentiated thyroid carcinomas. Histopathology 2003;42:580-587.
31. Kato N, Tsuchiya T, Tamura G, Motoyama T. E-cadherin expression in follicular carcinoma of the thyroid. Pathol Int 2002;52:13-18.
32. Brecelj E, Frkovic GS, Auersperg M, Bracko M. Prognostic value of Ecadherin expression in thyroid follicular carcinoma. Eur J Surg Oncol 2005;31:544-548.
33. Yokoyama K, Kamata N, Hayashi E, et al. Reverse correlation of Ecadherin and snail expression in oral squamous cell carcinoma cells in vitro. Oral Oncol 2001;37:65-71.
34. Cano A, Perez-Moreno MA, Rodrigo I, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000;2:76-83.
35. Takes RP, Baatenburg De Jong RJ, Alles MJ, et al. Markers for nodal metastasis in head and neck squamous cell cancer. Arch Otolaryngol Head Neck Surg 2002;128:512-518.
36. Blanco MJ, Moreno-Bueno G, Sarrio D, et al. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 2002;21:3241-3246.
37. Sugimachi K, Tanaka S, Kameyama T, et al. Transcriptional repressor snail and progression of human hepatocellular carcinoma. Clinical Cancer Res 2003;9:2657-2664.
38. Loercher A, Lee TL, Ricker JL, et al. Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma. Cancer Res 2004;64:6511-6523.
39. Paget, S. The distribution of secondary growths in cancer of the breast. Lancet 1889;1:571-573.
40. Chen Z, Malhotra PS, Thomas GR, et al. Expession of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res 1999;5:1369-1379.
41. Ondrey FG, Dong G, Sunwoo J, et al. Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines. Mol Carcinog 1999;26:119-129.
42. St.John MA, Li Y, Zhou X, et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004;130:929-935.
43. Witta SE, Gemmill RM, Hirsch FR, et al. Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines. Cancer Res 2006;66:944-950.
44. Krysan K, Lee JM, Dohadwala M, et al. Inflammation, epithelial to mesenchymal transition, and epidermal growth factor receptor tyrosine kinase inhibitor resistance. J Thorac Oncol 2008;3:107-110.